awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-E981F84A-E6ED-4FE0-A0A2-A70C2DE3C620
Q42720284-E981F84A-E6ED-4FE0-A0A2-A70C2DE3C620
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-E981F84A-E6ED-4FE0-A0A2-A70C2DE3C620
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P50
Q42720284-E981F84A-E6ED-4FE0-A0A2-A70C2DE3C620
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-E981F84A-E6ED-4FE0-A0A2-A70C2DE3C620
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de794169a8f7bb04f7552c33bb22286fcc60dfa
P1545
14
http://www.w3.org/2001/XMLSchema#string
P1932
Farhad Ravandi
http://www.w3.org/2001/XMLSchema#string
P50
Farhad Ravandi